Molecular Partners Ag (MOLN) Price to Sales (2021 - 2024)

Molecular Partners Ag (MOLN) has reported Price to Sales for 4 consecutive years, with 33.61 the latest figure, recorded in Q4 2024.

• On a quarterly basis, Price to Sales rose 75.34% year-over-year to 33.61 in Q4 2024; TTM through Jun 2026 was 27.4, a 31.82% increase from a year earlier, with the FY2024 full-year figure at 33.72, up 73.89% from the prior year.
• Price to Sales was 33.61 for Q4 2024 at Molecular Partners Ag, down from 235280.85 in the prior quarter.
• Over five years, Price to Sales peaked at 235280.85 in Q3 2024 and troughed at 1.2 in Q4 2022.
• A 4-year average of 42871.11 and a median of 485.75 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales slumped 97.95% in 2022 and jumped 2608.51% in 2023, its largest moves.
• Over 4 years, Price to Sales stood at 58.6 in 2021, then tumbled by 97.95% to 1.2 in 2022, then jumped by 1496.34% to 19.17 in 2023, then soared by 75.34% to 33.61 in 2024.
• The last three Price to Sales figures came in at 33.61 (Q4 2024), 235280.85 (Q3 2024), and 153.25 (Q2 2024), per Business Quant data.